Their management is setting up a good offering price, which is alright

No scam here, just great science, great fiscal Management and a CEO fixated on precision rather than stock price.

Management has done nothing wrong.

The logical and much more direct conclusion is that management is telling the truth and that Blarcamesine is an extraordinarily promising compound the very likely will become a Blockbuster approved drug in the future.

$AVXL at such a bargain price, zero open market buy from the management tells you all you need to know.

$AVXL Beyond Bullish, downright crazy for the stock, the drug, the management, the whole damn company.

Mgt prospect strong sales growth in 2023 !

That is how strong management feels Also China is looking to grow economy and US trying to shrink.

Emed will have a huge market for their devices and imo will revolutionize the pain management industry.

$BABA I love it when @scorpfx and like minded individuals trade stocks on macro news, they will never make real money, long term investing is buying a business that has the strength, management, financial prowess to get through tough times.